Breast Cancer

Locally Advanced or Metastatic 1st or 2nd Line

A Phase III Randomized, Double-Blind, Placebo-Controlled Study of LEE011 or Placebo in Combination with Tamoxifen and Goserelin OR a Non-Steroidal Aromatase Inhibitor (NSAI) and Goserelin for the Treatment of Pre-Menopausal Women with Hormone Receptor Positive Her 2 Negative Advanced Breast Cancer –    Novartis - MONALEESA – 7  - # - CLEE011E2301